 |
市場調查報告書
商品編碼
1672750
維生素和礦物質補充劑錠劑市場按類型、應用、分銷管道和地區分類Vitamin and Mineral Supplement Tablets Market, By Type, By Application, By Distribution Channel, By Geography |
||||||
2025 年全球維生素和礦物質補充劑錠劑市場規模估計為 166.9 億美元，預計到 2032 年將達到 233.5 億美元，2025 年至 2032 年的複合年成長率為 4.9%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 166.9億美元 |
| 效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
| 預測期：2025-2032年複合年成長率： | 4.90％ | 2032 年價值預測 | 233.5億美元 |
維生素和礦物質補充劑是人體無法自行產生的必需營養素。它們在維持身體健康方面發揮著重要作用，並有助於彌補飲食中任何潛在的營養缺陷。由於人們健康意識的增強、人均醫療支出的增加以及文明病和缺乏症的盛行率增加等因素，維生素和礦物質補充劑錠劑市場正在經歷顯著成長。高壓力水平和垃圾食品的消費導致身體最佳功能所需的必需維生素和礦物質攝取不足。這導致對膳食補充劑的需求增加，以確保最佳營養。
市場動態
全球維生素和礦物質補充劑錠劑市場的成長得益於消費者健康意識的增強、新興市場人均收入的提高、產品形式的便利性以及補充劑品牌的推廣。然而，複雜的法律規範、農村地區缺乏認知以及過量攝取消費可能產生的副作用是市場相關人員面臨的一些挑戰。機會在於擴展到尚未開發的農村市場，推出滿足不斷變化的客戶需求的創新新產品，利用電子商務的繁榮，並透過社群媒體行銷和宣傳計畫宣傳健康益處。
本研究的主要特點
本報告對全球維生素和礦物質補充錠劑市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。
它揭示了不同領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球維生素和礦物質補充錠劑市場的主要企業根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行分析。
主要企業包括大塚製藥、NutraScience Labs、Glanbia plc、葛蘭素史克公司、美國康寶萊國際公司、Bactolac Pharmaceutical, Inc.、Noreva Biotech、Pharmavite、Brunel Healthcare、雀巢、輝瑞公司、雅培、拜耳公司、美國健康公司等。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球維生素和礦物質補充錠劑市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球維生素和礦物質補充錠劑市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管情景
- 產品發布/核准
- PEST分析
- PORTER 分析
- 併購情景
- 市場趨勢
4. 維生素和礦物質補充錠劑市場，按類型，2020-2032 年（十億美元）
- 維生素補充劑
- 礦物質補充劑
5. 維生素和礦物質補充錠劑市場，按應用分類，2020-2032 年（十億美元）
- 一般健康
- 骨骼和關節健康
- 免疫支持
- 其他
6. 維生素和礦物質補充錠劑市場，按分銷管道，2020-2032 年（十億美元）
- 藥局和藥局
- 超級市場和大賣場
- 其他
7. 維生素和礦物質補充錠劑市場，按地區，2020-2032 年（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- Otsuka Pharmaceutical Co., Ltd.
- NutraScience Labs
- Glanbia plc
- GSK plc
- Herbalife International of America, Inc.
- Bactolac Pharmaceutical, Inc.
- Noreva Biotech
- Pharmavite
- Brunel Healthcare
- Nestle
- Pfizer, Inc.
- Abbott
- Bayer AG
- American Health, Inc.
第9章分析師建議
第10章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global Vitamin And Mineral Supplement Tablets Market is estimated to be valued at USD 16.69 Bn in 2025 and is expected to reach USD 23.35 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 16.69 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.90% | 2032 Value Projection: | USD 23.35 Bn |
Vitamin and mineral supplements are essential nutrients that bodies cannot produce by themselves. These play a crucial role in maintaining good health and help fill potential nutrient gaps in diets. Vitamin and mineral supplement tablets market has witnessed tremendous growth, owing to factors such as increasing health awareness among people, growing per capita healthcare expenditures, and rising prevalence of lifestyle diseases and deficiency disorders. High stress levels and junk food consumption have led to inadequate intake of essential vitamins and minerals necessary for optimum body functioning. This has boosted demand for dietary supplements to ensure optimum nutrition.
Market Dynamics
Global vitamin and mineral supplement tablets market growth is driven by rising health consciousness among consumers, growing per capita income in developing nations, convenience of product formats, and promotion by supplement brands. However, complex regulatory framework, lack of awareness in rural areas, and potential side-effects of excessive intake are challenges faced by market players. Opportunity lies in expanding to untouched rural markets, innovative new product launches catering to evolving customer needs, leveraging the e-commerce boom, and promoting the health advantages through social media marketing and advocacy programs.
Key features of the study
This report provides in-depth analysis of the global vitamin and mineral supplement tablets market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vitamin and mineral supplement tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Otsuka Pharmaceutical Co., Ltd., NutraScience Labs, Glanbia plc, GSK plc, Herbalife International of America, Inc., Bactolac Pharmaceutical, Inc., Noreva Biotech, Pharmavite, Brunel Healthcare, Nestle, Pfizer, Inc., Abbott, Bayer AG, and American Health, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global vitamin and mineral supplement tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vitamin and mineral supplement tablets market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Vitamin Supplements
- Vitamin A
- Vitamin B
- Vitamin C
- Vitamin D
- Others
- Mineral Supplements
- Calcium
- Iron
- Zinc
- Magnesium
- Others
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- General Health
- Bone & Joint Health
- Immune Support
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmacies & Drug Stores
- Supermarkets & Hypermarkets
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Otsuka Pharmaceutical Co., Ltd.
- NutraScience Labs
- Glanbia plc
- GSK plc
- Herbalife International of America, Inc.
- Bactolac Pharmaceutical, Inc.
- Noreva Biotech
- Pharmavite
- Brunel Healthcare
- Nestle
- Pfizer, Inc.
- Abbott
- Bayer AG
- American Health, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Vitamin and Mineral Supplement Tablets Market, By Type
- Vitamin and Mineral Supplement Tablets Market, By Application
- Vitamin and Mineral Supplement Tablets Market, By Distribution Channel
- Vitamin and Mineral Supplement Tablets Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Market Trends
4. Vitamin and Mineral Supplement Tablets Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Vitamin Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vitamin A
- Vitamin B
- Vitamin C
- Vitamin D
- Others
- Mineral Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Calcium
- Iron
- Zinc
- Magnesium
- Others
5. Vitamin and Mineral Supplement Tablets Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- General Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bone & Joint Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immune Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Vitamin and Mineral Supplement Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmacies & Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Supermarkets & Hypermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Vitamin and Mineral Supplement Tablets Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Otsuka Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NutraScience Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glanbia plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GSK plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Herbalife International of America, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bactolac Pharmaceutical, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Noreva Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pharmavite
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Brunel Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nestle
- Pfizer, Inc.
- Abbott
- Bayer AG
- American Health, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
